Start Low, Go Slow: Why Jumping Straight to High-Dose Methylfolate Could Be Making You Worse

If you've recently been told you have MTHFR and discovered that methylfolate is the form you should be taking, you may be tempted to start at the highest dose you can find — 5mg, 10mg, even 15mg. More is better, right? Not with methylfolate.

For a significant proportion of people — particularly those with slow COMT variants, slow MAO-A variants, or depleted B12 — starting high can produce a paradoxical worsening of the very symptoms you're trying to address. This is often called the methylfolate start reaction, or overmethylation.

What overmethylation is

Overmethylation occurs when methylation support is introduced faster than the downstream pathways can process it. Excess SAMe production follows, and with it a cascade of neurotransmitter effects: anxiety, irritability, insomnia, racing thoughts, palpitations and general neurological agitation.

For slow COMT individuals this is particularly relevant. COMT clears dopamine and noradrenaline in the prefrontal cortex using SAMe as its methyl donor. When SAMe surges, the system can pass through a period of catecholamine excess before rebalancing — see COMT, dopamine and chronic anxiety for the mechanism.

The start low, go slow approach

The cautious approach is to begin at the lowest dose you can source — often 100–200mcg — and hold it for two to four weeks before increasing. Standard tablets, including ours, are typically 400mcg, so in practice this can mean splitting a tablet or dosing every second day at first. If symptoms worsen at any dose, hold there until they settle rather than pushing on.

Adequate B12 before starting matters too. Methylfolate drives homocysteine into the remethylation pathway, and that reaction requires methylcobalamin as a cofactor. Without enough B12 the pathway becomes rate-limited — which is one reason methylated B vitamins are generally taken together rather than as isolated methylfolate. The reasoning is set out in active vs inactive B vitamins.

When to get guidance

If you experience significant worsening when starting, or you take medications affecting neurotransmitter levels — particularly SSRIs, SNRIs or MAO inhibitors — work with a practitioner familiar with methylation before proceeding. The interaction between methylfolate and serotonergic medication needs careful management.

Related: why MTHFR affects people so differently and the practical guide to living with MTHFR.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. Always consult your GP before beginning any new supplement programme, particularly if you are on prescription medications.